Description

[1-(3-Methyl-Benzyl)-3-Oxo-Piperazin-2-Yl]-Acetic Acid is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a versatile building block for creating novel therapeutic agents. It is primarily utilized by pharmaceutical manufacturers, biotechnology firms, and contract research organizations (CROs) focused on developing new drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel small-molecule drugs targeting various therapeutic areas.
• API Development: Used in research and process development for new Active Pharmaceutical Ingredients (APIs), particularly in oncology and central nervous system (CNS) drug discovery.
• Medicinal Chemistry Research: Serves as a crucial scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for cGMP production of clinical trial materials and commercial APIs.
• Bioconjugation: Potential use in the development of antibody-drug conjugates (ADCs) or other targeted drug delivery systems due to its functional groups.
• Chemical Reference Standard: Sourced by analytical laboratories for use as a high-purity reference standard in quality control and method validation.

Basic Information

Item	Details
Product Name	[1-(3-Methyl-Benzyl)-3-Oxo-Piperazin-2-Yl]-Acetic Acid
CAS No.	1023919-68-7
Molecular Formula	C15H20N2O3
Molecular Weight	276.33 g/mol
Synonyms	2-[(1-[(3-Methylphenyl)methyl]-3-oxo-2-piperazinyl]acetic acid; (1-(3-Methylbenzyl)-3-oxopiperazin-2-yl)acetic acid; 1-(3-Methylbenzyl)-3-oxopiperazine-2-acetic acid; 1023919-68-7; 1-(3-Methyl-benzyl)-3-oxo-piperazin-2-yl-acetic acid; 1-(3-Methylbenzyl)-2-(carboxymethyl)-3-piperazinone
EINECS	Contact for details

Quality Control

Our [1-(3-Methyl-Benzyl)-3-Oxo-Piperazin-2-Yl]-Acetic Acid is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the stringent requirements for pharmaceutical R&D and manufacturing. Certificates of Analysis (COA) detailing all specifications and test results are provided with each shipment and are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive); keep the container tightly sealed in a dry environment to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.